Showing 1 - 10 of 45
Persistent link: https://www.econbiz.de/10009404246
Persistent link: https://www.econbiz.de/10010614318
Persistent link: https://www.econbiz.de/10009404280
Objective: To describe the pharmacoeconomic assessment process in Ireland and to provide examples of recent appraisals and the subsequent impact on pricing and reimbursement decisions. Method: The pharmacoeconomic appraisals conducted by the National Centre for Pharmacoeconomics (NCPE) between...
Persistent link: https://www.econbiz.de/10008602824
Background: It has been estimated that major orthopaedic surgery has the highest risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) when compared with other surgery. Two new orally active anticoagulants have recently become licensed in Ireland for the primary prevention...
Persistent link: https://www.econbiz.de/10008459673
Persistent link: https://www.econbiz.de/10012489771
Cost estimates for the drug of interest, its comparator and concomitant drugs are an important component of pharmacoeconomic evaluations. However, whilst in general considerable efforts are made by analysts to ensure valid and accurate parameter inputs, the methods for estimating drug costs are...
Persistent link: https://www.econbiz.de/10004969762
Cost estimates for the drug of interest, its comparator and concomitant drugs are an important component of pharmacoeconomic evaluations. However, whilst in general considerable efforts are made by analysts to ensure valid and accurate parameter inputs, the methods for estimating drug costs are...
Persistent link: https://www.econbiz.de/10010848939
Given the variance reported between survivors and decedents, future projections should include PTD in their models to improve accuracy. Policies targeted at reducing expenditures should not focus on age but on ensuring appropriate and cost-effective prescribing, particularly towards the end of...
Persistent link: https://www.econbiz.de/10011152169
Persistent link: https://www.econbiz.de/10005167141